Table 2.

American Society for Gastrointestinal Endoscopy (ASGE) and American Society for Metabolic and Bariatric Surgery (ASMBS) recommendations for endoscopic bariatric and metabolic therapies (EBMTs).

	ASGE AND ASMBS SUMMARY RECOMMENDATIONS FOR EBMTS
I.	For primary obesity therapies in patients with obesity class I, II, and III, a minimum goal of 25% excess weight loss at 12 months
II.	For nonprimary EBMTs including metabolic therapy, bridging to surgery, and early intervention, a goal of ≥ 5% total weight loss
III.	For serious adverse events, ≤ 5% is recommended for all EBMTs